No evidence for cardiotoxicity of miltefosine – Reply
AUTOR(ES)
Barroso, Daniel Holanda; Gomes, Ciro Martins; Silva, Antônia Marilene da; Sampaio, Raimunda Nonata Ribeiro
FONTE
Anais Brasileiros de Dermatologia
DATA DE PUBLICAÇÃO
2022
RESUMO
Documentos Relacionados
- No evidence for cardiotoxicity of miltefosine
- Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis
- The evidence base for shaken baby syndrome: Authors' reply
- Assessing the need for booster vaccination — A reply
- Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence.